By HT Correspondent | Edited by Abhinav Sahay | PTI, Raipur

UPDATED ON JAN 10, 2021 08:08 AM IST

  • Bharat Biotech obtained DCGI approval for section 3 scientific trials in 26,000 contributors in over 25 centres throughout India, based on the corporate web site

Get our every day e-newsletter in your inbox

Thanks for subscribing to our every day e-newsletter.

Close

Source

Leave a Reply